Sofinnova Partners Sas Hookipa Pharma Inc

As of April 23, 2021


Sofinnova Partners Sas Net Worth

  • Net worth is estimated to be at least $125.73M
  • Owns at least 3,177,574 units of Hookipa Pharma Inc stock
  • Sold an estimated value of $20.44M in the last 2 years at Hookipa Pharma Inc

Sofinnova Partners Sas Trading

  • Largest purchase of shares was 3,881,398 units , worth over $5M on April 25, 2019
  • Largest sale of shares was 328,620 units , worth over $3.81M on April 23, 2021
  • In total has made about 28 transactions over 2 years
  • Usually trades in March, with the busiest year in 2021

Monique Saulnier Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SAS, Sofinnova Partners SAS

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Sofinnova Partners Sas Mailing Address

  • Mailing address is 17 Rue de Serene Paris I0 75008 France

Hookipa Pharma Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Joern Aldag 2020 $495,102 $49,082 $1,081,912 $297,940 - $1,924,036
Joern Aldag 2019 $469,205 - $5,617,254 $281,522 - $6,367,981
Reinhard Kandera 2020 $373,806 $24,208 $418,700 $175,137 $13,132 $1,004,983
Reinhard Kandera 2019 $352,248 - $814,250 $169,079 $12,902 $1,348,479
Igor Matushansky 2020 $399,750 $32,531 $352,703 $189,322 $13,862 $988,168
Igor Matushansky 2019 $393,538 - $483,675 $177,092 $88,409 $1,142,714
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1760542/000110465921052076/tm212666-1_def14a.htm

Hookipa Pharma Inc Insider Trading

  • The most recent transaction was 14,949 units sold on January 12, 2022 by Igor Matushansky worth over $37.22K
  • In the last 2 years, insiders at Hookipa Pharma Inc sold an estimated value of $11.2M and bought an estimated value of $18.27M
  • The most active traders are Monique Saulnier Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners Sas,  Sofinnova Partners Sas,  and Igor Matushansky, Chief Medical Officer
  • Insider trading is most common in April, with the busiest year in 2020

HOOKIPA Pharma Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1